低剂量的乙氨基通过小鼠的阿片类系统产生抗抑郁药类效应
Behnam Ghorbanzadeh1, Behnam Azizolahi2, Farnaz Masoudipur1
1Department of Pharmacology, School of Medicine, Dezful University of Medical Sciences, Dezful, Iran.
Behavioural brain research
|May 23, 2024
概括
乙氨基在小鼠中表现出类似抗抑郁药的效果,由阿片类系统调解. 与吗啡不同,它不会引起耐受性或戒断,这表明它是一种更安全的抑郁症管理替代方案.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 精神病学是一个精神病学.
背景情况:
- 乙氨基 (偏醇) 是一种广泛使用的止痛药和抗发烧药.
- 越来越多地认识到阿片类药物途径在抑郁症病理生理学中的作用.
- 有限的研究存在于乙氨基的抗抑郁药类效应.
研究的目的:
- 为了调查阿片类受体对乙氨基类似抗抑郁药的作用的参与.
- 评估急性和次慢性乙氨基给药对小鼠抑郁症样行为的影响.
主要方法:
- 用小鼠强迫游泳测试 (FST) 来评估类似抗抑郁药的活性.
- 乙氨基单独和与纳洛 (非选择性阿片类受体对抗剂) 或吗啡联合使用,剂量不同 (25-400 mg/kg).
- 在重复服用乙氨基后,评估了耐受性和戒断综合征.
- 用RT-PCR分析海马的mu-和kappa-opioid受体的mRNA表达.
主要成果:
- 低剂量的乙氨基 (50和100毫克/公斤) 在FST中产生抗抑郁作用,这种作用被纳洛减少.
- 更高剂量的乙氨基 (200和400毫克/公斤) 是无效的.
- 一种非有效的乙氨基剂量被吗啡强化,这种效果被纳洛阻断.
- 不同于吗啡,重复服用乙氨基并没有诱导耐受性或戒断综合征.
- 乙氨基增加了海马体的mu和kappa-opioid受体的mRNA表达,而吗啡没有影响kappa-opioid受体的表达.
结论:
- 乙氨基具有剂量依赖的抗抑郁药类活性,主要是在较低剂量的情况下.
- 观察到的乙氨基的抗抑郁作用可能是通过阿片类药物系统进行的,涉及海马体的mu和kappa受体.
- 乙氨基对传统阿片类药物具有潜在的治疗优势,因为它缺乏耐受性和戒断诱导.
相关概念视频
Antidepressant Drugs: MAOIs and Other Agents
225
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
225
Analgesia and Pain Management
582
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
582
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
370
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
370
Opioid Analgesics: Synthetic and Semisynthetic Opioids
279
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
279
CNS Depressants: Alcohol and Nicotine
203
Ethanol, a clear colorless alcohol, has been consumed by humans for millennia, but its effects on the body are far from benign. At lower doses, it induces decreased inhibitions and loquaciousness, leading to its social appeal. However, it can cause severe consequences at higher doses, such as coma and respiratory depression, due to its zero-order elimination kinetics. Chronic ethanol abuse wreaks havoc on multiple organ systems, particularly the CNS and the liver. Abrupt cessation of ethanol...
203
Sedatives and Hypnotics Drugs: Miscellaneous Agents
170
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
170


